These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11833049)

  • 21. Characterization of an apolipoprotein E3 variant (Arg 145-->His) associated with mild hypertriglyceridemia.
    Hidaka H; Tozuka M; Hidaka E; Yamauchi K; Ota H; Honda T; Katsuyama T
    Ann Clin Lab Sci; 2001 Apr; 31(2):163-70. PubMed ID: 11337906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformation of apolipoprotein E both in free and in lipid-bound form may determine the avidity of triglyceride-rich lipoproteins to the LDL receptor: structural and kinetic study.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):14-28. PubMed ID: 10685027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virus-mediated transduction of apolipoprotein E (ApoE)-sendai develops lipoprotein glomerulopathy in ApoE-deficient mice.
    Ishigaki Y; Oikawa S; Suzuki T; Usui S; Magoori K; Kim DH; Suzuki H; Sasaki J; Sasano H; Okazaki M; Toyota T; Saito T; Yamamoto TT
    J Biol Chem; 2000 Oct; 275(40):31269-73. PubMed ID: 10903326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy.
    Oikawa S; Matsunaga A; Saito T; Sato H; Seki T; Hoshi K; Hayasaka K; Kotake H; Midorikawa H; Sekikawa A; Hara S; Abe K; Toyota T; Jingami H; Nakamura H; Sasaki J
    J Am Soc Nephrol; 1997 May; 8(5):820-3. PubMed ID: 9176854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular metabolism of triglyceride-rich lipoproteins.
    Heeren J; Beisiegel U
    Curr Opin Lipidol; 2001 Jun; 12(3):255-60. PubMed ID: 11353327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein E-related glomerular disorders.
    Saito T; Matsunaga A; Fukunaga M; Nagahama K; Hara S; Muso E
    Kidney Int; 2020 Feb; 97(2):279-288. PubMed ID: 31874799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy.
    Bomback AS; Song H; D'Agati VD; Cohen SD; Neal A; Appel GB; Rovin BH
    Nephrol Dial Transplant; 2010 Oct; 25(10):3442-6. PubMed ID: 20624773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.
    Wu H; Yang Y; Hu Z
    J Atheroscler Thromb; 2018 Aug; 25(8):733-740. PubMed ID: 29398675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.
    Saito T; Matsunaga A; Oikawa S
    Am J Kidney Dis; 2006 Feb; 47(2):199-211. PubMed ID: 16431249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two apolipoprotein E5 variants illustrate the importance of the position of additional positive charge on receptor-binding activity.
    Wardell MR; Rall SC; Schaefer EJ; Kane JP; Weisgraber KH
    J Lipid Res; 1991 Mar; 32(3):521-8. PubMed ID: 1648586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Identification of a mutation in exon 4 of apolipoprotein E gene in a family affected with lipoprotein glomerulopathy].
    Han HL; Lin S; Sun LS; Zhang P; Zhai DP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):141-4. PubMed ID: 22487820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal lipoprotein and apolipoprotein pattern in lipoprotein glomerulopathy.
    Oikawa S; Suzuki N; Sakuma E; Saito T; Namai K; Kotake H; Fujii Y; Toyota T
    Am J Kidney Dis; 1991 Nov; 18(5):553-8. PubMed ID: 1951334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E.
    Raffai RL; Dong LM; Farese RV; Weisgraber KH
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11587-91. PubMed ID: 11553788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of cysteine 158, the glycosylation site threonine 194, the amino- and carboxy-terminal domains of apolipoprotein E in the binding to amyloid peptide beta (1-40).
    Aleshkov SB; Li X; Lavrentiadou SN; Zannis VI
    Biochemistry; 1999 Jul; 38(28):8918-25. PubMed ID: 10413465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice.
    Wu H; Yang J; Liu YQ; Lei S; Yang M; Yang Z; Yang Y; Hu Z
    J Transl Med; 2021 Mar; 19(1):97. PubMed ID: 33663537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel apolipoprotein E mutation, ApoE Tsukuba (Arg 114 Cys), in lipoprotein glomerulopathy.
    Hagiwara M; Yamagata K; Matsunaga T; Arakawa Y; Usui J; Shimizu Y; Aita K; Nagata M; Koyama A; Zhang B; Mastunaga A; Saku K; Saito T
    Nephrol Dial Transplant; 2008 Jan; 23(1):381-4. PubMed ID: 17967799
    [No Abstract]   [Full Text] [Related]  

  • 37. Thermodynamic destabilization and aggregation propensity as the mechanism behind the association of apoE3 mutants and lipoprotein glomerulopathy.
    Katsarou M; Stratikos E; Chroni A
    J Lipid Res; 2018 Dec; 59(12):2339-2348. PubMed ID: 30309894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thermodynamic and structural destabilization of apoE3 by hereditary mutations associated with the development of lipoprotein glomerulopathy.
    Georgiadou D; Stamatakis K; Efthimiadou EK; Kordas G; Gantz D; Chroni A; Stratikos E
    J Lipid Res; 2013 Jan; 54(1):164-76. PubMed ID: 23110818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topics in lipoprotein glomerulopathy: an overview.
    Saito T; Matsunaga A; Ito K; Nakashima H
    Clin Exp Nephrol; 2014 Apr; 18(2):214-7. PubMed ID: 24149835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological and genetic characteristics in Chinese patients with lipoprotein glomerulopathy.
    Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Li LS
    J Nephrol; 2008; 21(1):110-7. PubMed ID: 18264944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.